NeoGenomics Inc. Common Stock vs Victoria's Secret & Co — how do they compare? NeoGenomics Inc. Common Stock trades at $17 (market cap $2.17B), while Victoria's Secret & Co trades at $88 (market cap $7.05B). The key difference: Victoria's Secret & Co is far larger — about 3.2× NeoGenomics Inc. Common Stock's market cap, and NeoGenomics Inc. Common Stock is more actively traded (1,615,943 versus 1,022,828). Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Victoria's Secret & Co for 34 Days on average.
| NEO | VSXY | |
|---|---|---|
Market Cap | $2.17B | $7.05B |
Volume | 1,615,943 | 1,022,828 |
Sector | Health | Consumer Cyclical |
52-Week High | $19.91 | $99.97 |
52-Week Low | $7.19 | $30.19 |
Typical Hold Time | 0 Days | 34 Days |
Enterprise Value | $2.47B | $9.43B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →